Short Summary
Mercedes‑Benz has filed an IPR petition seeking cancellation of all 20 claims of U.S. Patent 9,045,101, arguing they are anticipated or obvious over existing driver‑authentication and vehicle‑monitoring technologies. The petition cites multiple prior‑art references and argues that discretionary factors favor institution.
Detailed Summary
In a corrected petition for inter partes review, Mercedes‑Benz Group AG challenges claims 1‑20 of U.S. Patent No. 9,045,101, which covers a vehicle driver‑authentication and monitoring system. The petitioner asserts six grounds of unpatentability, relying on statutes 102 and 103, and cites prior‑art references including Murphy (U.S. Patent 6,225,890), Schanz (German publication DE10323723A1), Petrik (U.S. application 2007/0168125 A1), and Benco (U.S. application 2008/0136611A1). Each ground targets either all claims or claim 10 specifically. The petition further argues that discretionary considerations under §§314(a) and 325(d) strongly favor institution, referencing the Fintiv factors and the Advanced Bionics framework. No claim constructions or expert testimonies are presented, and the proceeding is currently at the petition stage awaiting the Board’s institution decision.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Mercedes-Benz Group AG et al. vs Phelan Group, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Imperative Care, Inc.vsINARI MEDICAL, INC.
The PTAB instituted an IPR on Inari Medical’s 11,697,012 B2 hemostasis valve patent after finding Imperative Care likely to prevail on at least one claim, based on anticipation and obviousness arguments over Schaffer, Hartley, Eller, and Garrison references.
PacifiCorp et al.vsMES, Inc.
MidAmerican Energy Company and BirchTech Corp. have settled their dispute over U.S. Patent 10,926,218 and filed a joint motion to terminate the inter partes review. The motion cites statutory authority and public‑policy reasons favoring settlement before any merits decision.
Google LLCvsSonos, Inc.
Google LLC has filed an IPR petition seeking cancellation of all 20 claims of Sonos’s U.S. Patent No. 10,541,883. The petition asserts that the claims are obvious over prior‑art references Cheshire, Meenan, and Spurgat under 35 U.S.C. §103.
Amgen Inc. et al.vsBristol-Myers Squibb Company
Amgen’s request for Director Review of IPR denial is rebuffed by Bristol‑Myers Squibb, which argues the petitioner offers no credible basis and that European prosecution does not affect settled expectations for the U.S. patent.
Microsoft CorporationvsDialect, LLC
Microsoft and Dialect reached a settlement that led both parties to jointly move to terminate the inter partes review of patent 7,634,409 before the Board made an institution decision.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.